|
ASX - By Stock
|
ATX |
Re:
Ann: Narmafotinib Large-Scale Manufacture Complete
|
|
Garyb29336
|
8 |
2.5K |
11 |
25/01/26 |
| 25/01/26 |
ASX - By Stock
|
8
|
2.5K
|
11
|
|
|
ASX - By Stock
|
ATX |
Re:
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
|
|
Garyb29336
|
44 |
12K |
14 |
03/01/26 |
| 03/01/26 |
ASX - By Stock
|
44
|
12K
|
14
|
|
|
ASX - By Stock
|
ATX |
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
|
|
Garyb29336
|
44 |
12K |
15 |
24/12/25 |
| 24/12/25 |
ASX - By Stock
|
44
|
12K
|
15
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Additional Confirmed Response Reported-Investor Presentation
|
|
Garyb29336
|
9 |
4.4K |
3 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
9
|
4.4K
|
3
|
|
|
ASX - By Stock
|
ATX |
Re:
News
|
|
Garyb29336
|
17 |
3.8K |
0 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
17
|
3.8K
|
0
|
|
|
ASX - By Stock
|
ATX |
Re:
News
|
|
Garyb29336
|
17 |
3.8K |
0 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
17
|
3.8K
|
0
|
|
|
ASX - By Stock
|
ATX |
Re:
News
|
|
Garyb29336
|
17 |
3.8K |
1 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
17
|
3.8K
|
1
|
|
|
ASX - By Stock
|
ATX |
Re:
News
|
|
Garyb29336
|
17 |
3.8K |
1 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
17
|
3.8K
|
1
|
|
|
ASX - By Stock
|
ATX |
Re:
News
|
|
Garyb29336
|
17 |
3.8K |
0 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
17
|
3.8K
|
0
|
|
|
ASX - By Stock
|
ATX |
Re:
ATX - General discussion
|
|
Garyb29336
|
530 |
183K |
7 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
530
|
183K
|
7
|
|
|
ASX - By Stock
|
ATX |
Re:
News
|
|
Garyb29336
|
17 |
3.8K |
0 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
17
|
3.8K
|
0
|
|
|
ASX - By Stock
|
ATX |
News
|
|
Garyb29336
|
17 |
3.8K |
8 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
17
|
3.8K
|
8
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ADDITIONAL RESPONSES IN ACCENT PANCREATIC CANCER TRIAL
|
|
Garyb29336
|
43 |
12K |
5 |
29/11/25 |
| 29/11/25 |
ASX - By Stock
|
43
|
12K
|
5
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: FIRST PATIENT DOSED IN NEW PANCREATIC CANCER TRIAL
|
|
Garyb29336
|
28 |
9.7K |
3 |
10/11/25 |
| 10/11/25 |
ASX - By Stock
|
28
|
9.7K
|
3
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Commences Trading on U.S. OTCQB Venture Market
|
|
Garyb29336
|
17 |
4.9K |
10 |
08/11/25 |
| 08/11/25 |
ASX - By Stock
|
17
|
4.9K
|
10
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Commences Trading on U.S. OTCQB Venture Market
|
|
Garyb29336
|
17 |
4.9K |
1 |
31/10/25 |
| 31/10/25 |
ASX - By Stock
|
17
|
4.9K
|
1
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Commences Trading on U.S. OTCQB Venture Market
|
|
Garyb29336
|
17 |
4.9K |
2 |
31/10/25 |
| 31/10/25 |
ASX - By Stock
|
17
|
4.9K
|
2
|
|
|
ASX - By Stock
|
ATX |
Re:
ATX - General discussion
|
|
Garyb29336
|
530 |
183K |
0 |
28/10/25 |
| 28/10/25 |
ASX - By Stock
|
530
|
183K
|
0
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ADDITIONAL RESPONSES IN ACCENT PANCREATIC CANCER TRIAL
|
|
Garyb29336
|
43 |
12K |
16 |
11/10/25 |
| 11/10/25 |
ASX - By Stock
|
43
|
12K
|
16
|
|
|
ASX - By Stock
|
ATX |
Re:
ATX - General discussion
|
|
Garyb29336
|
530 |
183K |
5 |
11/10/25 |
| 11/10/25 |
ASX - By Stock
|
530
|
183K
|
5
|
|
|
ASX - By Stock
|
ATX |
Re:
ATX - General discussion
|
|
Garyb29336
|
530 |
183K |
3 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
530
|
183K
|
3
|
|
|
ASX - By Stock
|
ATX |
Re:
Life Science Virtual Investor Conferences
|
|
Garyb29336
|
7 |
2.0K |
3 |
20/09/25 |
| 20/09/25 |
ASX - By Stock
|
7
|
2.0K
|
3
|
|
|
ASX - By Stock
|
ATX |
Re:
Life Science Virtual Investor Conferences
|
|
Garyb29336
|
7 |
2.0K |
8 |
20/09/25 |
| 20/09/25 |
ASX - By Stock
|
7
|
2.0K
|
8
|
|
|
ASX - By Stock
|
ATX |
Re:
Life Science Virtual Investor Conferences
|
|
Garyb29336
|
7 |
2.0K |
1 |
20/09/25 |
| 20/09/25 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
|
ASX - By Stock
|
ATX |
Re:
Life Science Virtual Investor Conferences
|
|
Garyb29336
|
7 |
2.0K |
4 |
20/09/25 |
| 20/09/25 |
ASX - By Stock
|
7
|
2.0K
|
4
|
|
|
ASX - By Stock
|
ATX |
Re:
Life Science Virtual Investor Conferences
|
|
Garyb29336
|
7 |
2.0K |
1 |
20/09/25 |
| 20/09/25 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
|
ASX - By Stock
|
ATX |
Life Science Virtual Investor Conferences
|
|
Garyb29336
|
7 |
2.0K |
3 |
20/09/25 |
| 20/09/25 |
ASX - By Stock
|
7
|
2.0K
|
3
|
|
|
ASX - By Stock
|
ATX |
Re:
ATX - General discussion
|
|
Garyb29336
|
530 |
183K |
5 |
15/09/25 |
| 15/09/25 |
ASX - By Stock
|
530
|
183K
|
5
|
|
|
ASX - By Stock
|
ATX |
Re:
ATX in the US under INNMF.
|
|
Garyb29336
|
3 |
1.2K |
1 |
21/08/25 |
| 21/08/25 |
ASX - By Stock
|
3
|
1.2K
|
1
|
|
|
ASX - By Stock
|
ATX |
ATX in the US under INNMF.
|
|
Garyb29336
|
3 |
1.2K |
13 |
20/08/25 |
| 20/08/25 |
ASX - By Stock
|
3
|
1.2K
|
13
|
|
|
ASX - By Stock
|
ATX |
Re:
ATX - General discussion
|
|
Garyb29336
|
530 |
183K |
7 |
18/08/25 |
| 18/08/25 |
ASX - By Stock
|
530
|
183K
|
7
|
|
|
ASX - By Stock
|
ATX |
Re:
The ticker symbol in the US is INNMF
|
|
Garyb29336
|
4 |
1.6K |
4 |
14/08/25 |
| 14/08/25 |
ASX - By Stock
|
4
|
1.6K
|
4
|
|
|
ASX - By Stock
|
ATX |
Re:
The ticker symbol in the US is INNMF
|
|
Garyb29336
|
4 |
1.6K |
4 |
14/08/25 |
| 14/08/25 |
ASX - By Stock
|
4
|
1.6K
|
4
|
|
|
ASX - By Stock
|
ATX |
The ticker symbol in the US is INNMF
|
|
Garyb29336
|
4 |
1.6K |
9 |
14/08/25 |
| 14/08/25 |
ASX - By Stock
|
4
|
1.6K
|
9
|
|
|
ASX - By Stock
|
XJO |
The ticker symbol in the US is INNMF.
|
|
Garyb29336
|
0 |
224 |
0 |
14/08/25 |
| 14/08/25 |
ASX - By Stock
|
0
|
224
|
0
|
|